Skip to main content

Year: 2020

Delårsrapport 1 januari – 30 september 2020

FORTSATT STABIL OPERATIV UTVECKLING, FÖRVÄRV AV RUN COMMUNICATIONS, GENOMFÖRD OBLIGATIONSEMISSION 300-450 MSEKDet tredje kvartalet var framgångsrikt. Stockwik genomförde en obligationsfinansiering som utgör en stabil grund för fortsatt expansion och vi förvärvade datalagringsföretaget RUN Communications. I koncernen fortsatte verksamheten och portföljbolagen att stabilisera sig i spåren av pandemin. Totalt har Stockwik klarat sig fortsatt bra. Portföljbolagen var intakta och de flesta verksamheterna i stort opåverkade. På rullande tolv månader utföll såväl omsättning som resultat oförändrat i koncernen totalt (proforma, dvs med alla befintliga verksamheter inräknade oavsett när de tillträddes). Alla fyra segment uppvisade också var för sig stabila omsättningssiffror och underliggande resultat. I ljuset av hur världen sett ut är det riktigt...

Continue reading

Europe Animal Transportation Market to Reach USD 516.75 Million by 2027; Increasing Rate of Pet Adoption in France and UK will aid Growth, says Fortune Business Insights™

Pune, Nov. 13, 2020 (GLOBE NEWSWIRE) — The Europe animal transportation market size is projected to reach USD 516.75 million by the end of 2027. The increasing dairy and farming industry across the world will emerge in favor of market growth. According to a report published by Fortune Business Insights, titled “Europe Animal Transportation Market Size, Share & COVID-19 Impact Analysis, By Animal (Cattle, Pigs, Poultry, Pets, Sheep & Goats, and Others), Type (Personal and Commercial), Regional Forecast, 2020 – 2027” the market was worth USD 408.46 million and will exhibit a CAGR of 4.3% during the forecast period, 2020-2027.Animal transportation is an important aspect of several industry verticals across the world. The usage of transportation is higher in sectors such as farming and dairy industries will emerge in favor...

Continue reading

Interim financial report Q1 – Q3 2020

”I’m pleased with the upgraded outlook for 2020 announced on 29 October 2020 following a strong rebound of the UK market and an effective cost management. With these effects H+H can report solid margin defence showing an improved gross margin and EBITDA margin year to date in line with last year”, says CEO Michael T. Andersen.Financial highlights for the period 1 January to 30 September 2020HighlightsCurrent trading in the majority of our markets perform as expected with overall stable development in Germany and softening of the Polish market.During the third quarter of 2020, we have seen recovery in the UK market after the lockdown where distribution centres and building sites closed in the end of March 2020 due to covid-19. The lockdown affected the market throughout the second quarter of 2020 with gradual re-opening in the end of the...

Continue reading

Saga Tankers ASA: Q3 2020 financial results

(Oslo, 13 November 2020) Saga Tankers ASA (“Saga”, OSE: SAGA) reported a net asset value (NAV) of NOK  242 million end of the third quarter 2020, corresponding to NOK 0.91 per outstanding share, excluding minority interests and with Vallhall valued at book value.By the end of the third quarter, Saga had a cash balance of NOK 91 million, excluding cash held in the subsidiary Vallhall, that  has been reclassified as assets held for sale and liabilities held for sale, pending the subsequent disposal.During the quarter Saga distributed a dividend of NOK 0.1 per share, corresponding to NOK 26.7 million.The net market value of shares held in SD Standard Drilling Plc decreased by NOK 7.4 million and the shares in Vistin Pharma ASA increased by NOK 11.2 million. Net NOK 3.8 million has been classified as net gain from available for sale assets....

Continue reading

Kiadis announces presentations at the 2020 ASH Annual Meeting and Exposition

Amsterdam, The Netherlands, November 13, 2020 – Kiadis Pharma N.V. (“Kiadis” or the “Company”) (Euronext Amsterdam and Brussels: KDS), a clinical-stage biopharmaceutical company developing innovative NK-cell-based medicines for the treatment of life-threatening diseases, today announces that five abstracts related to its K-NK-cell therapy platform were accepted for presentation at the 62nd American Society of Hematology (ASH) Annual Meeting and Exposition being held virtually from December 5-8, 2020.The ASH abstracts are now available online through the ASH conference website at www.hematology.org/Annual-Meeting/Abstracts/.Details of the oral presentation are as follows:Oral Presentation #68: Haploidentical MbIL-21 Ex Vivo Expanded NK Cells (FC21-NK) for Patients with Multiple Relapsed and Refractory Acute Myeloid...

Continue reading

Itafos Reports Q3 2020 Financial Results and Operational Highlights

TORONTO, Nov. 13, 2020 (GLOBE NEWSWIRE) — Itafos (TSX-V: IFOS) (the “Company”) reported today its Q3 2020 financial results and operational highlights. The Company’s financial statements and management’s discussion and analysis for the three and nine months ended September 30, 2020 are available under the Company’s profile at www.sedar.com and on the Company’s website at www.itafos.com. All dollar values are in thousands of US Dollars except as otherwise noted.“Q3 2020 was dominated by a significant disruption in sulfuric acid supply at Conda from our primary supplier. Our team did an outstanding job to mitigate the impact by procuring additional sulfuric acid volumes from other third party suppliers and opportunistically conducting certain maintenance activities during times of lower throughput. These efforts, in addition to the...

Continue reading

BIGG Digital Assets Inc. Announces Upsize of Previously Announced Overnight Marketed Public Offering to $6 Million

NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE U.S.VANCOUVER, British Columbia, Nov. 12, 2020 (GLOBE NEWSWIRE) — BIGG Digital Assets Inc. (“BIGG” or the “Company”) (CSE: BIGG; OTCQB: BBKCF; WKN: A2PS9W) is pleased to announce that, due to strong investor demand, it has increased its previously announced overnight public marketed offering to 25,000,000 units of the Company (“Units”) at a price of $0.24 per Unit for gross proceeds of approximately $6 million (the “Offering”).The Offering is being conducted by a syndicate of underwriters led by PI Financial Corp. and including Canaccord Genuity Corp., Echelon Wealth Partners, Haywood Securities Inc. and M Partners Inc. (collectively, the “Underwriters”). The Company will shortly file an amended and restated preliminary short form prospectus (the “AR Preliminary...

Continue reading

Orocobre Limited – Results of the 2020 Annual General Meeting

BRISBANE, Australia, Nov. 13, 2020 (GLOBE NEWSWIRE) — Orocobre Limited (ASX: ORE, TSX: ORL) (“Orocobre” or “the Company”) wishes to announce that all resolutions were passed as ordinary resolutions following a poll at the Annual General Meeting held this morning, 13 November 2020.Details of the votes cast are provided on the following page.This announcement has been authorised by:Rick AnthonJoint Company SecretaryFor more information please contact:Andrew BarberInvestor Relations ManagerOrocobre LimitedT: +61 7 3871 3985M: +61 418 783 701E: abarber@orocobre.comW: www.orocobre.comTwitter: https://twitter.com/OrocobreLimitedLinkedIn: https://www.linkedin.com/company/orocobre-limitedFacebook: https://www.facebook.com/OrocobreLimited/Instagram: https://www.instagram.com/orocobre/YouTube: https://www.youtube.com/OrocobreLimitedClick...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.